Rethinking the carcinogenesis of breast cancer: The theory of breast cancer as a child deficiency disease or a pseudo semi-allograft

被引:0
|
作者
Lund, Eiliv [1 ,2 ]
Busund, Lill-Tove Rasmussen [1 ,3 ]
Thalabard, Jean-Christophe [4 ]
机构
[1] UiT Arctic Univ Norway, Tromso, Norway
[2] Canc Registry Norway, Oslo, Norway
[3] Univ Hosp North Norway, Tromso, Norway
[4] Univ Paris 05, USPC, UMR CNRS 8145, MAP5, Paris, France
关键词
Breast cancer; Theory; Semi-allograft; Integrated systems epidemiology; Parity; Immune response; Pseudo semi-allograft; NORWEGIAN WOMEN; RISK-FACTORS; PREGNANCY; CONTRACEPTIVES; MECHANISMS; REANALYSIS; TOLERANCE; CELLS;
D O I
10.1016/j.mehy.2018.08.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The theory of breast cancer as a child deficiency disease is an inversion of the current paradigm, which considers full term pregnancies to be a protective factor and uses nulliparous women as the reference group. Instead, the theory of breast cancer as a child deficiency disease says that women with the highest parity (about 20, which is the limit of human fertility) are those with the lowest risk and should be used as the reference group in risk estimations. This theory is explained biologically by converting parity from the simple value of number of children into an understanding of the long-lasting biological and immunological effects of pregnancy. These effects can be reflected, as measured by functional genomics, in gene expression of the immune cells in the blood. Each pregnancy represents a unique fetus or semi-allograft, which provokes the creation and deposit of memory cell clones in the mother. Gene expression levels have been found to change linearly with number of full-term pregnancies in healthy women, but not in breast cancer patients. High hormone levels are necessary for a successful pregnancy, as they modulate the immune response from adaptive to innate in order to protect the fetus (considered as a semi-allograft) from rejection. At the end of the pregnancy, hormone levels drop, and the immune system recognizes the semi-allograft, but not in time for rejection to occur before birth. High hormones levels are also classified as carcinogens illustrating that carcinogenesis in the breast could be viewed as a war or balance between later exposures to hormonal carcinogens and the protection of the immune system. We propose that breast tumors are pseudo semi-allografts made up of transformed breast tissue cells. Assuming that the sensitivity to the exposure to increased levels of endogenous or exogenous hormones in women with breast cancer mimic those that occur in pregnancy, these breast tumor cells are protected against the body's immune reaction, just as the fetus is during pregnancy. However, with more pregnancies, the potential to eradicate the pseudo semi-allograft might increase due to enhanced immune surveillance. The theory of breast cancer as a child deficiency disease proposes that the protective effect of pregnancy on breast cancer incidence via the immune system is independent of other risk factors.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 50 条
  • [41] Rethinking Breast Cancer Screening: Ultra FAST Breast Magnetic Resonance Imaging
    Morris, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (22) : 2281 - U145
  • [42] Persistent organochlorine compounds and their role for the carcinogenesis of breast cancer
    Bauer, M
    Hilpert, F
    Meinhold-Heerlein, I
    Jonat, W
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2004, 64 (07) : 681 - 689
  • [43] The role of vitamin D in the carcinogenesis of breast and ovarian cancer
    Walentowicz-Sadlecka, Malgorzata
    Sadlecki, Pawel
    Walentowicz, Pawel
    Grabiec, Marek
    GINEKOLOGIA POLSKA, 2013, 84 (04) : 305 - 308
  • [44] Targeting the subtypes of breast cancer: rethinking investigational drugs
    Curigliano, Giuseppe
    Locatelli, Marzia
    Fumagalli, Luca
    Brollo, Janaina
    Munzone, Elisabetta
    Nole, Franco
    Criscitiello, Carmen
    Goldhirsch, Aron
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (02) : 191 - 204
  • [45] Breast cancer - advanced disease
    Karanikolic, A.
    Djordjevic, N.
    Pesic, M.
    Milic, D.
    Budjevac, D.
    Djordievic, I.
    Pesic, I.
    EJC SUPPLEMENTS, 2005, 3 (02): : 121 - 121
  • [46] BENIGN BREAST DISEASE AND CANCER
    MITCHELL, GW
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1986, 29 (03): : 705 - 714
  • [47] BREAST CANCER AND THYROID DISEASE
    BOGARDUS, GM
    FINLEY, JW
    SURGERY, 1961, 49 (04) : 461 - 468
  • [48] Breast cancer as an infectious disease
    Lawson, James S.
    Glenn, Wendy K.
    Whitaker, Noel J.
    WOMENS HEALTH, 2010, 6 (01) : 5 - 8
  • [49] Cardiovascular disease and breast cancer
    Moey, Melissa
    Moslehi, Javid
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (04) : 200 - +
  • [50] Breast Cancer - a Lifestyle Disease?
    Janni, Wolfgang
    BREAST CARE, 2018, 13 (02) : 84 - 85